MedPath

Hydralazine Hydrochloride

Approved
Approval ID

04b4c1c2-093c-4f48-a6b4-3e290fae51b4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 16, 2011

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

hydralazine hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6266
Application NumberANDA040730
Product Classification
M
Marketing Category
C73584
G
Generic Name
hydralazine hydrochloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJune 16, 2011
FDA Product Classification

INGREDIENTS (7)

METHYLPARABENInactive
Quantity: 0.65 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.35 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
HYDRALAZINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: FD171B778Y
Classification: ACTIB
PROPYLENE GLYCOLInactive
Quantity: 103.6 mg in 1 mL
Code: 6DC9Q167V3
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hydralazine Hydrochloride - FDA Drug Approval Details